Identifying biomarkers for neurodevelopmental disorders linked to inflammation during pregnancy
Official title: Predictive BioMArkers of AlTERed NeurologicAL Trajectories Consequent to PrenataL
Run by Istituto Clinico Humanitas · NCT06852703 · Data updated 2026-11-12
This study is trying to find signs that could help predict neurodevelopmental disorders in kids whose moms had inflammation during pregnancy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Istituto Clinico Humanitas Academic / other |
| Locations | 1 site (Pisa, PI) |
| Status | Recruiting |
| Started | September 1, 2021 |
| Main results expected | April 30, 2024 |
| Study ends | August 31, 2025 |
| Registry record updated | February 28, 2025 |
| Trial ID | NCT06852703 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women aged 18 to 40 with a normal BMI and no significant medical or obstetric history.
✕Probably not a fit
Patients with pre-gestational diabetes, multiple pregnancies, or significant obstetric complications will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify predictive biomarkers for neurodevelopmental disorders in children whose mothers experienced inflammation during pregnancy. It will involve 300 pregnant women and their children, with biological samples collected at various stages of pregnancy to assess immune responses. The study will also utilize a controlled mouse model to explore the molecular mechanisms connecting maternal inflammation to altered brain development. The integration of these approaches seeks to provide early indicators and potential intervention strategies for affected children.
Why it matters
Potential benefit: If successful, this study could lead to early identification and intervention strategies for neurodevelopmental disorders in children.
How similar studies have gone: While the association between maternal inflammation and neurodevelopmental disorders is established, this specific approach to identifying biomarkers is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Age between 18 and 40 years. BMI between 18 kg/m2 and 25 kg/m2. Negative remote medical history for chronic conditions (rheumatological, immunological, endocrinological). Negative obstetric history for significant pathologies (pre-eclampsia, gestational diabetes, preterm birth). Reassuring combined test Exclusion Criteria: * Pre-gestational diabetes * Multiple pregnancy * Threatened preterm labor and/or premature rupture of membranes * Pre-eclampsia * Intrauterine growth restriction (IUGR) * Fetal macrosomia (biometrics \>90th percentile) * Chromosomal syndromes, genetic conditions, or multiple fetal malformations or major fetal malformations * Withdrawal of informed consent * Smoking patients are not excluded from the study, nor are patients who develop gestational diabetes during pregnancy.
Where it's running
-
Aoup
Pisa, Pi, Italy Recruiting
Study contacts
- Study coordinator: Antonella Pisano, Dr.
- Email: contratti.ricerca@humanitas.it
- Phone: +39 02 82244501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions
This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Melillo Method for kids with behavior and learning challenges
This pilot test will see if the Melillo Method can be feasibly delivered in two Illinois schools to help kids aged 8 and up who have behavioral and learning difficulties.
-
Understanding how sensory brain signals vary in people with and without neurodevelopmental disorders
This study tests whether people with neurodevelopmental disorders show more variation in brain responses to sensory stimulation than people without these disorders.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.